SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Pennington Biomedical Research Center Receives FDA Approval to Begin Phase I Studies of Compellis Pharmaceuticals' Novel and Patented Obesity Therapy